Citation Impact

Citing Papers

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Recognition and treatment of sleep-disordered breathing: an important component of chronic disease management
2017
Titanium dioxide nanoparticles: a review of current toxicological data
2013 Standout
Lung cancer in patients with idiopathic pulmonary fibrosis
2017
Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5
2006
Idiopathic pulmonary fibrosis
2017 Standout
Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
2016
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis
2017
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
Cefuroxime axetil in acute purulent exacerbations of chronic bronchitis
1987
Serum biomarkers in idiopathic pulmonary fibrosis
2010
Depression Is a Risk Factor for Noncompliance With Medical Treatment
2000 Standout
Idiopathic Pulmonary Fibrosis
2007
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
2012
Predictors of Sleep-Disordered Breathing in Community-Dwelling Adults<subtitle>The Sleep Heart Health Study</subtitle>
2002 Standout
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature
2012
A global view of pulmonary hypertension
2016 Standout
Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis
2019 Standout
Titanium dioxide nanoparticles cause apoptosis in BEAS-2B cells through the caspase 8/t-Bid-independent mitochondrial pathway
2010
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
2007 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
2019 Standout
Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect
2011
Sarcoidosis
2013 Standout
Quantitative Computerized Two-Point Correlation Analysis of Lung CT Scans Correlates With Pulmonary Function in Pulmonary Sarcoidosis
2012
Interstitial lung disease guideline
2008
Colchicine in clinical medicine. A guide for internists
2010
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
The impact of emphysema in pulmonary fibrosis
2013
Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study
2008
Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP)
2001
Patient Adherence and Medical Treatment Outcomes
2002 Standout
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
2013
Obstructive Sleep Apnea Is Common in Idiopathic Pulmonary Fibrosis
2009
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury
2009
Does Chronic Microaspiration Cause Idiopathic Pulmonary Fibrosis?
2010
Idiopathic Pulmonary Fibrosis
2004
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
EMT: 2016
2016 Standout
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Oxidative Stress in Cancer
2020 Standout
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
2007 Standout
Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy
2016
Melatonin as a natural ally against oxidative stress: a physicochemical examination
2011 Standout
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
2015
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis – The Predictive Value of Exercise Capacity and Gas Exchange Efficiency
2013
Glutathione synthesis
2012 Standout
Global burden of chronic pulmonary aspergillosis complicating sarcoidosis
2012
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
2009
Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis
2017
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Oxidative stress and glutathione in TGF-β-mediated fibrogenesis
2009
Idiopathic pulmonary fibrosis
2011 Standout
Sarcoidosis
2007 Standout
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
2015
Epidemiology of idiopathic pulmonary fibrosis
2013
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Heat shock proteins in fibrosis and wound healing: Good or evil?
2014
A Novel IκB Kinase-β Inhibitor Ameliorates Bleomycin-induced Pulmonary Fibrosis in Mice
2006
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Obstructive Sleep Apnea and Subclinical Interstitial Lung Disease in the Multi-Ethnic Study of Atherosclerosis (MESA)
2017
Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation
2015
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Redox-Based Therapeutics for Lung Diseases
2008
Oxidative Stress, Plasminogen Activator Inhibitor 1, and Lung Fibrosis
2007
Alveolar Oxidative Stress is Associated with Elevated Levels of Nonenzymatic Low-Molecular-Weight Antioxidants in Patients with Different Forms of Chronic Fibrosing Interstitial Lung Diseases
2008
Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis
2011
First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
2010
Branhamella catarrhalis: an organism gaining respect as a pathogen
1990 Standout
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2015 Standout
A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
1997
Acute and subacute idiopathic interstitial pneumonias
2016
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
The Use and Misuse of New Antibiotics
1995
Non-steroid agents for idiopathic pulmonary fibrosis
2010
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Malondialdehyde in Exhaled Breath Condensate as a Marker of Oxidative Stress in Different Pulmonary Diseases
2011
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Idiopathic Pulmonary Fibrosis
2018 Standout
Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation
2015
The importance, status, and perspectives of hybrid lanthanide-doped upconversion nanothermometers for theranostics
2022
Integrating mechanisms of pulmonary fibrosis
2011 Standout

Works of V. Polychronopoulos being referenced

Temperature differences are associated with malignancy on lung lesions: a clinical study
2003
Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters
2011
Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis
2006
Epidemiology of interstitial lung diseases in Greece
2009
Sleep Quality and Associated Daytime Consequences in Patients with Idiopathic Pulmonary Fibrosis
2008
Health-related quality of life in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (overlap syndrome)
2007
Overexpression of Bcl-2 Protein in Bronchoalveolar Lavage Lymphocytes and Macrophages in Sarcoidosis
2005
Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis
2006
How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?
2010
Apoptosis in lung injury and fibrosis
2008
Acute interstitial pneumonia
2000
A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections
1985
Rankless by CCL
2026